key: cord-0847814-r3z0xv5w authors: Huang, Fei; Liu, Xu; Sun, Xiaolin; Li, Zhanguo title: IL‐10 served as an indicator in severe COVID‐19 patients date: 2020-10-30 journal: J Med Virol DOI: 10.1002/jmv.26580 sha: 7de6a1f86dd775542aebc7823e3867535dff3dab doc_id: 847814 cord_uid: r3z0xv5w The higher levels of cytokine storm may be associated with more severe COVID-19 disease development. In this study, we performed a systemic analysis to investigate whether the cytokines can help predict clinical severity in patients with COVID-19. This article is protected by copyright. All rights reserved. To the Editor, Recently, the coronavirus disease 2019 (COVID-19) pandemic has reached more than 32,730,000 confirmed cases and over 991,000 deaths worldwide. Accumulated evidence suggests that severe COVID-19 patients have an immune response disorder, leading to excessive inflammation. 1 Moreover, recent studies have reported that inflammatory cytokines are associated with the severity of COVID-19. 2 However, there is limited systemic analysis to clarify the role of various inflammatory cytokines in the assessment of COVID-19 severity. Therefore, we performed a literature analysis to investigate the association of cytokines and lymphocyte subsets between severe and nonsevere COVID-19 patients. Databases of Medline (PubMed), Embase, Cochrane, and Web of Sciences from January 1 to September 1, 2020, were systematically analyzed to identify all published studies in the English language, using the following keywords: "2019-nCoV" OR "SARS-CoV-2" OR "COVID-19" OR "new coronary pneumonia" OR "corona virus" OR "novel coronavirus" OR "nCoV" OR "coronavirus 2019." The title, abstract, and full text of all the documents meeting these search criteria were scrutinized by two independent investigators, and only those containing data on cytokines and lymphocyte subsets of COVID-19 patients with and without severe disease (i.e., those requiring intensive care unit admission, mechanical ventilation, vital life support, or those who died) were included in our analysis. The reference lists of relevant literature were also manually screened to identify other eligible studies. Overall, 18 studies were considered in the final analysis. 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Mean and standard deviation of lymphocyte subsets and cytokines values were extrapolated from the sample size, median, and interquartile range for statistical homogeneity. 20 Meta-analysis was per- Figure 1B ). Based on these analyses, this study has enhanced the significance of lymphocytes and cytokines in the severity of COVID-19 coronavirus disease. and differentiate into specific effector T cells, producing a variety of pro-inflammatory cytokines. 21 Here, we find that severe COVID-19 was associated with the elevated cytokines, in particular IL-10. There were reduced T, B, NK, CD4+ T, CD8+ T, and CD28+ Ts cells, while activated Ts cells percentages were increased. Thus, monitoring the changes of IL-10 has an important implication for the prediction and treatment of severe COVID-19 patients who may get critically ill. This study has several limitations. First, studies included were mainly retrospective cohorts. The interpretation of some findings may be limited by the sample size. However, with appropriate statistical tools, we were able to identify several indicators to indicate disease severity in patients with COVID-19. In addition, only the articles containing both lymphocyte subsets and cytokines were included to ensure the two sets of data from the same cohort of patients. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19 Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients Clinical and immunological features of severe and moderate coronavirus disease 2019 Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan Clinical features of 69 cases with coronavirus disease Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up The clinical course and its correlated immune status in COVID-19 pneumonia Correlation between relative nasopharyngeal virus RNA load and lymphocyte count disease severity in patients with COVID-19 Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui A retrospective study on the epidemiological characteristics and establishment of an early warning system of severe COVID-19 patients Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China Analysis of clinical characteristics of 49 cases of COVID-19 Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019 Leucocyte subsets effectively predict the clinical outcome of patients with COVID-19 pneumonia: a retrospective case-control study Clinical and pathological investigation of patients with severe COVID-19 Relationship between chest CT manifestations and immune response in COVID-19 patients Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range Cytokine storm and sepsis disease pathogenesis